Aurobindo Pharma rises on receiving USFDA approval for Sodium Chloride injection
Aurobindo Pharma rises on receiving USFDA approval for Sodium Chloride injection

Aurobindo Pharma rises on receiving USFDA approval for Sodium Chloride injection

Chinmayee D Article rating: 4.3

The company will manufacture Dexmedetomidine Hydrochloride in 0.9 per cent Sodium Chloride injection, in the strengths of 200 µg/50 ml and 400 µg/100 ml single doses in flexible containers (bags). The injection is said to launch in January 2021.

Stocks that are likely to record significant movement on bourses today
Stocks that are likely to record significant movement on bourses today

Stocks that are likely to record significant movement on bourses today

Karan Dsij Article rating: 4.4

JSW Steel: The crude steel production for the month of November 2020 was at 13.32 lakh tonnes, showing a growth of 3 per cent YoY. The average capacity utilisation was 89 per cent during the month of November 2020. The shortage of iron ore remained a constraint in November 2020 to achieve higher capacity utilisation.

SGX Nifty indicates positive opening; PSU Bank stocks-PNB & Bank of Baroda witness huge open interest addition
SGX Nifty indicates positive opening; PSU Bank stocks-PNB & Bank of Baroda witness huge open interest addition

SGX Nifty indicates positive opening; PSU Bank stocks-PNB & Bank of Baroda witness huge open interest addition

Karan Dsij Article rating: 4.7

The unabated journey continued for the Indian markets on Tuesday as well with both the indices, Sensex & Nifty logging fresh record highs. However, it was a tough row to hoe for the bulls as extinct bears fought their heart to gain supremacy but all in vain as the recovery in the second half of the trading session once again provided an advantage to the bulls.

Nifty trend for Wednesday
Nifty trend for Wednesday

Nifty trend for Wednesday

Karan Dsij Article rating: 4.5

On the upside, the resistance is placed around 13,435, followed by 13,535 levels. On the downside, support is seen around the 13,300 mark. As long as it trades above the 13,300 mark, buy-on-dips would be a prudent strategy.

Mphasis features as Bollinger Band Squeeze pick
Mphasis features as Bollinger Band Squeeze pick

Mphasis features as Bollinger Band Squeeze pick

Vinayak Gangule Article rating: 3.6

The stock of Mphasis Limited has been picked up by our Bollinger Band Squeeze scanner, which suggests that the stock is near a consolidation breakout.

Bank of Baroda forms record session count pattern; bulls may take a breather
Bank of Baroda forms record session count pattern; bulls may take a breather

Bank of Baroda forms record session count pattern; bulls may take a breather

Vinayak Gangule Article rating: 3.6

This is an extremely rare pattern and usually occurs at the top of an uptrend. Generally, we rely on the typical momentum indicators or oscillators for recognising an overbought and oversold condition of the stock. However, this Japanese candlestick pattern gives us a unique way to recognise the time when the momentum is about to wane out.

Indoco Remedies to launch its first own-label product in Europe
Indoco Remedies to launch its first own-label product in Europe

Indoco Remedies to launch its first own-label product in Europe

Shreya Chaware Article rating: 3.6

Indoco Remedies announced today about winning major tenders in Germany, including AOK for Allopurinol tablets. This is the first time that the company would be launching its own label product in Europe.

Canara Bank sets floor price for QIP; stock jumps 8 per cent
Canara Bank sets floor price for QIP; stock jumps 8 per cent

Canara Bank sets floor price for QIP; stock jumps 8 per cent

Deepti Shidore Article rating: 3.8

Canara Bank Ltd, one of the largest public sector banks in India, is set to raise Rs 2,000 crore by way of qualified institutional placement (QIP). Reacting to the news, its stock gained 8 per cent on Tuesday.

RSS
First23732374237523762378238023812382Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR